Industry Action

A single company can only do so much. Just as a single country cannot keep out multiple drug-resistant bacteria. In the fight against AMR, we have therefore taken on a high-profile campaigning role. We do this by calling on both the industry and the entire value chain to act responsibly and stop buying, using or selling irresponsibly made antibiotics. We aim to create awareness that industrial antibiotics pollution significantly contributes to antimicrobial resistance and that sustainable and responsible production of antibiotics is not only imperative, but also economically feasible.

This was acknowledged with the publication of the Review on AMR report, issued by the UK government, in May 2016.

 

Key Industry initiatives

 

A number of key initiatives within the industry have been deployed to actively battle the rise of AMR.

Davos Declaration

UN Industry Roadmap

AMR Industry Alliance

In January 2016, along with over 100 other companies and trade associations, we signed a declaration at the World Economic Forum in Davos to undertake collective action in the fight against antibiotic resistance.

 

In this Declaration on Combating AMR, signatories call on governments to work with them to develop new and alternative market structures that provide more dependable and sustainable market models for antibiotics. Signatory companies also committed themselves to reduce the growth of antimicrobial resistance, to invest in R&D, and to improve access to high-quality antibiotics and vaccines.

 

Read more

In September 2016, the UN Industry Roadmap for Progress on Combating AMR was presented at the UN General Assembly in New York. We were one of the driving forces in establishing the UN Industry Roadmap, which was signed by 13 leading pharmaceutical companies, including DSP.

 

With the reduction of the environmental impact of antibiotics production as one of the four commitments in the Industry Roadmap, this topic is now firmly on the agenda of leading pharmaceutical companies and others.

 

Read more

In May 2017 the launch of the AMR Industry Alliance was announced at the B20 Health Conference in Berlin. The AMR Industry Alliance ties the two initiatives of the Davos Declaration and the UN Industry Roadmap and brings together a wide-range of stakeholders. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Declaration and the Roadmap,  and will measure progress made in the fight against antimicrobial resistance.

 

Read more

Winner of the Cefic European Responsible Care Award

Source: CEFIC

In 2016 we received the prestigious Cefic European Responsible Care Award in the Product Stewardship Category, for our work on Sustainable Antibiotics. Cefic (the European Chemical Industry Council) runs the award as part of its efforts to strengthen the Responsible Care initiative, the global industry’s commitment to sustainability, and to encourage the use of best practices across Europe.

 

Read more about our memberships here.

Copyright © 2017 DSM Sinochem Pharmaceuticals

Join the conversation

Follow us on Facebook Follow us on Twitter Follow us on LinkedIn
  • Davos Declaration

    In January 2016, along with over 100 other companies and trade associations, we signed a declaration at the World Economic Forum in Davos to undertake collective action to create a sustainable and predictable market for antibiotics, vaccines and diagnostics, and to coordinate

    activities to improve the prevention of infections, hygiene, stewardship and conservation measures.

     

    In the Declaration, signatories call on governments to work with them to develop new and alternative market structures that provide more dependable and sustainable market models for antibiotics. Signatory companies also committed themselves to reduce the growth of antimicrobial resistance, to invest in R&D, and to improve access to high-quality antibiotics and vaccines.

     

    Read more

  • UN Industry Roadmap

    In September 2016, the UN Industry Roadmap for Progress on Combating AMR was presented at the UN General Assembly in New York. We were one of the driving forces in establishing the UN Industry Roadmap, which was signed by 13 leading pharmaceutical companies, including DSP.

     

    With the reduction of the environmental impact of antibiotics production as one of the four commitments in that Roadmap, this topic is now firmly on the agenda of leading pharmaceutical companies and others.

     

    Read more

  • AMR Industry Alliance

    In May 2017 the launch of the AMR Industry Alliance was announced at the B20 Health Conference in Berlin. The AMR Industry Alliance ties the two initiatives of the Davos Declaration and the UN Industry Roadmap and brings together a wide-range of stakeholders. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Declaration and the Roadmap and will measure progress made in the fight against antimicrobial resistance.

     

    Read more

DSM Sinochem Pharmaceuticals logo

A single company can only do so much. Just as a single country cannot keep out multiple drug-resistant bacteria. In the fight against AMR, we have therefore taken on a high-profile campaigning role. We do this by calling on both the industry and the entire value chain to act responsibly and stop buying, using or selling irresponsibly made antibiotics. We aim to create awareness that industrial antibiotics pollution significantly contributes to antimicrobial resistance and that sustainable and responsible production of antibiotics is not only imperative, but also economically feasible.

This was acknowledged with the publication of the Review on AMR report, issued by the UK government, in May 2016.

 

Key Industry initiatives

 

A number of key initiatives within the industry have been deployed to actively battle the rise of AMR.

In 2016 we received the prestigious Cefic European Responsible Care Award in the Product Stewardship Category, for our work on Sustainable Antibiotics. Cefic (the European Chemical Industry Council) runs the award as part of its efforts to strengthen the Responsible Care initiative, the global industry’s commitment to sustainability, and to encourage the use of best practices across Europe.

 

Read more about our memberships here.